DAVID DANTZKER - 13 Feb 2025 Form 4 Insider Report for SURMODICS INC (SRDX)

Role
Director
Signature
/s/ John Manders, on behalf of David R. Dantzker
Issuer symbol
SRDX
Transactions as of
13 Feb 2025
Net transactions value
-$11.06
Form type
4
Filing time
18 Feb 2025, 17:22:54 UTC
Previous filing
12 Feb 2024
Next filing
19 Nov 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SRDX Common Stock Options Exercise $144,008 +5,275 +13% $27.30 44,399 13 Feb 2025 Direct
transaction SRDX Common Stock Tax liability $144,019 -4,216 -9.5% $34.16 40,183 13 Feb 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SRDX Stock Option (right to buy) Options Exercise $0 -5,275 -100% $0.000000 0 13 Feb 2025 Common Stock 5,275 $27.30 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The amount beneficially owned includes 15,772 restricted stock units (RSUs) that vest on service-based vesting dates and 15,415 DSUs that are vested upon issuance, each of which will be settled in shares of the issuer's common stock on a 1 for 1 basis when the reporting person's service as a director ends.
F2 Fully vested.